Principia Biopharma (NASDAQ:PRNB) Given a $42.00 Price Target by Leerink Swann Analysts

Retrieved on: 2019-03-30 18:07:30

Tags for this article:

Click the tags to see associated articles and topics

Principia Biopharma (NASDAQ:PRNB) Given a $42.00 Price Target by Leerink Swann Analysts. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc acquired a new position in shares of Principia Biopharma in the 3rd quarter valued at $59,556,000. Baker BROS. Advisors LP ...</div>

Article found on:

View Original Article